|
|
| | 4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine Basic information |
| Product Name: | 4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine | | Synonyms: | 4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine;4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazole;7H-Pyrrolo[2,3-d]pyrimidine, 4-(1H-pyrazol-4-yl)-;Ruxolitinib Impurity G;4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine hydrochloride;Baricitinib Impurity 29;Ruxolitinib Diamine;4-(4-pyrazolyl)-7H-pyrrolo[2,3-d]pyrimidine | | CAS: | 952518-97-7 | | MF: | C9H7N5 | | MW: | 185.19 | | EINECS: | | | Product Categories: | | | Mol File: | 952518-97-7.mol | ![4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine Structure](CAS/20180601/GIF/952518-97-7.gif) |
| | 4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine Chemical Properties |
| | 4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine Usage And Synthesis |
| Uses | 4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazole is used in the preparation of deazapurines such as Ruxolitinib(R702000) which is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. Potent JAK2 inhibitor. |
| | 4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine Preparation Products And Raw materials |
|